Treatment and Diagnosis of Sexually Transmitted Diseases

• INTRODUCTION
• REASONS FOR STUDY
• SCOPE OF STUDY
• METHODLOGY AND INFORMATION SOURCES
• ANALYST CREDENTIALS
• RELATED BCC REPORTS
• EXECUTIVE SUMMARY
• INDUSTRY OVERVIEW
• DEFINITION OF SEXUALLY TRANSMITTED DISEASES
• EPIDEMIOLOGY AND ETIOLOGY OF SEXUALLY TRANSMITTED DISEASES
• PREVALENCE
  • HEALTH AND ECONOMIC CONSEQUENCES OF SEXUALLY TRANSMITTED DISEASES
  • TRENDS IN STDS
  • CLINICAL GUIDELINES FOR SEXUALLY TRANSMITTED DISEASES
  • PREVENTION OF SEXUALLY TRANSMITTED DISEASES
  • PREGNANCY AND SEXUALLY TRANSMITTED DISEASES
  • REGULATORY AND LEGISLATIVE ACTIONS FOR SEXUALLY TRANSMITTED DISEASES
  • CURRENT AND FUTURE NEEDS
• BACTERIAL VAGINOSIS
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR BACTERIAL VAGINOSIS
  • TREATMENTS FOR BACTERIAL VAGINOSIS
  • MARKET SIZE AND GROWTH FOR BACTERIAL VAGINOSIS
  • RESEARCH AND DEVELOPMENT FOR BACTERIAL VAGINOSIS
  • MARKET ANALYSIS
• CANDIDIASIS
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR CANDIDIASIS
  • TREATMENTS FOR CANDIDIASIS
  • MARKET SIZE AND GROWTH FOR CANDIDIASIS
  • RESEARCH AND DEVELOPMENT FOR CANDIDIASIS
  • MARKET ANALYSIS
• CHANCROID (VENERAL ULCERS)
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR CHANCROID
  • TREATMENTS FOR CHANCROID
  • MARKET SIZE AND GROWTH FOR CHANCROID
  • RESEARCH AND DEVELOPMENT IN CHANCROID
  • MARKET ANALYSIS
• CHLAMYDIA
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR CHLAMYDIA
  • TREATMENTS FOR CHLAMYDIA
  • MARKET SIZE AND GROWTH FOR CHLAMYDIA
  • RESEARCH AND DEVELOPMENT FOR CHLAMYDIA
  • MARKET ANALYSIS
• GENITAL HERPES
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR GENITAL HERPES
  • TREATMENTS FOR GENITAL HERPES
  • MARKET SIZE AND GROWTH FOR GENITAL HERPES
  • RESEARCH AND DEVELOPMENT FOR GENITAL HERPES
  • MARKET ANALYSIS
• GENITAL WARTS
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOTIC TREATMENT FOR GENITAL WARTS
  • TREATMENTS FOR GENITAL WARTS
  • MARKET SIZE AND GROWTH FOR GENITAL WARTS
  • RESEARCH AND DEVELOPMENT FOR GENITAL WARTS
  • MARKET ANALYSIS
• GONORRHEA
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR GONORRHEA
  • TREATMENTS FOR GONORRHEA
  • MARKET SIZE AND GROWTH FOR GONORRHEA
  • RESEARCH AND DEVELOPMENT FOR GONORRHEA
  • MARKET ANALYSIS
• HEPATITIS B
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR HEPATITIS B
  • TREATMENTS FOR HEPATITIS B
  • MARKET SIZE AND GROWTH FOR HEPATITIS B
  • RESEARCH AND DEVELOPMENT FOR HEPATITIS B
  • MARKET ANALYSIS
• HIV/AIDS
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR HIV.AIDS
  • TREATMENTS FOR HIV/AIDS
  • MARKET SIZE AND GROWTH FOR HIV/AIDS
  • RESEARCH AND DEVELOPMENT FOR HIV/AIDS
  • MARKET ANALYSIS
• PEDICULOSIS PUBIS
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR PEDICULOSIS PUBIS
  • TREATMENTS FOR PEDICULOSIS PUBIS
  • MARKET SIZE AND GROWTH FOR PEDICULOSIS PUBIS
  • RESEARCH AND DEVELOPMENT FOR PEDICULOSIS PUBIS
  • MARKET ANALYSIS
• SYPHILIS
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTICS FOR SYPHILIS
  • TREATMENTS FOR SYPHILIS
  • MARKET SIZE AND GROWTH FOR SYPHILIS
  • RESEARCH AND DEVELOPMENT FOR SYPHILIS
  • MARKET ANALYSIS
• TRICHOMONIASIS
  • OVERVIEW
  • RISK FACTORS
  • INCIDENCE/MORTALITY
  • DIAGNOSTIC TREATMENT FOR TRICHOMONIASIS
  • TREATMENTS FOR TRICHOMONIASIS
  • MARKET SIZE AND GROWTH FOR TRICHOMONIASIS
  • RESEARCH AND DEVELOPMENT FOR TRICHOMONIASIS
  • MARKET ANALYSIS
• THE OVERALL MARKET
• INTRODUCTION
  • TOTAL MARKET FOR THERAPEUTICS AND DIAGNOSTICS FOR SEXUALLY TRANSMITTED DISEASES
  • MARKET PERCENTAGE BY PRODUCT TYPE AND MARKET SEGMENT
  • INDUSTRY PARTICIPANTS BY PRODUCT TYPE
• COMPANY PROFILES
• NEW THERAPEUTICS AND DIAGNOSTICS FOR SEXUALLY TRANSMITTED DISEASES - PHARMACEUTICAL MANUFACTURERS
  • 3M PHARMACEUTICALS
  • ABBOTT LABORATORIES
  • BOEHRINGER INGELHEIM CORPORATION
  • BRISTOL-MYERS SQUIBB COMPANY
  • GLAXO WELLCOME, INC.
  • MERCK & COMPANY, INC.
  • NOVARTIS PHARMACEUTICAL CORPORATION
  • PHARMACIA CORPORATION
  • PFIZER, INC.
  • ROCHE LABORATORIES
  • SMITHKLINE BEECHAM PHARMACEUTICALS
• NEW THERAPEUTICS AND DIAGNOSTICS FOR SEXUALLY TRANSMITTED DISEASES  EMERGING PHARMACEUTICAL MANUFACTURERS
  • AVANIR PHARMACEUTICALS
  • BIOSYN, INC.
  • CANTAB PHARMACEUTICALS PLC
  • GILEAD SCIENCES, INC.
  • THE MEDICINES COMPANY
  • MEDIMMUNE, INC.
  • TRIANGLE PHARMACEUTICALS, INC.
  • VERTEX PHARMACEUTICALS
• APPENDIX: CURRENT PHARMACEUTICAL MANUFACTURERS, NAMES AND ADDRESSES

LIST OF TABLES

• SUMMARY TABLE:
  MARKET SIZE OF U.S. STD PRODUCTS BY REVENUES AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005

1. CAUSATIVE ORGANISM FOR SEXUALLY TRANSMITTED DISEASES
2. U.S. POPULATION BY AGE, 1990-2005
3. U.S. LIFE EXPECTANCY BY RACE AND SEX, 1990-1999
4. U.S. PREGNANT WOMEN WITH STDs, 1999
5. BACTERIAL VAGINOSIS U.S. INCIDENCE RATES, 1990-2005
6. MARKET SIZE OF U.S. BACTERIAL VAGINOSIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
7. BACTERIAL VAGINOSIS PRODUCTS IN DEVELOPMENT
8. BACTERIAL VAGINOSIS PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
9. CANDIDIASIS U.S. INCIDENCE RATES 1990-2005
10. MARKET SIZE OF U.S. CANDIDIASIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
11. CANDIDIASIS PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
12. CHANCROID (VENERAL ULCERS) U.S. INCIDENCE RATES, 1990-2005
13. MARKET SIZE OF U.S. CHANCROID (VENERIAL ULCER) PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
14. CHANCROID (VENERAL ULCERS) PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
15. CHLAMYDIA U.S. INCIDENCE RATES BY SEX, 1990-2005
16. CHLAMYDIA U.S. INCIDENCE RATES BY REGION, 1990-2005
17. MARKET SIZE OF U.S. CHLAMYDIA PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
18. CHLAMYDIA PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
19. GENITAL HERPES SIMPLEX VIRUS INFECTIONS U.S. INCIDENCE RATES BY SEX, 1990-2005
20. MARKET SIZE OF U.S. GENITAL HERPES PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
21. GENITAL HERPES PRODUCTS IN DEVELOPMENT
22. GENITAL HERPES PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
23. GENITAL WARTS U.S. INCIDENCE RATES BY SEX, 1990-2005
24. MARKET SIZE OF U.S. GENITAL WART PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
25. GENITAL WART PRODUCTS IN DEVELOPMENT
26. GENITAL WARTS PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
27. GONORRHEA U.S. INCIDENCE RATES BY SEX, 1990-2005
28. GONORRHEA U.S. INCIDENCE RATES BY REGION, 1990-2005
29. MARKET SIZE OF U.S. GONORRHEA PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
30. DRUGS IN DEVELOPMENT FOR GONORRHEA
31. GONORRHEA PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
32. HEPATITIS B INFECTION (SEXUALLY TRANSMITTED) U.S. INCIDENCE FOR BOTH SEXES, ALL AGES, ALL RACES, 1990-2005
33. MARKET SIZE OF U.S. HEPATITIS B PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
34. PR0DUCTS IN DEVELOPMENT FOR HBV
35. HEPATITIS B PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
36. MODES OF HIV TRANSMISSION
37. CDC CLASSIFICATION OF HIV INFECTION
38. HIV/AIDS U.S. INCIDENCE RATES BY SEX, AGE, AND RACE, 1990-2005
39. HIV/AIDS U.S. INCIDENCE BY SEX AND TRANSMISSION CATEGORY FOR BOTH SEXES, ALL AGES, AND ALL RACES, 1990-2005
40. U.S. AIDS DEATHS BY RACE, 1990-2000
41. HIV LIFE CYCLE
42. MARKET SIZE OF U.S. HIV/AIDS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
43. DRUGS IN DEVELOPMENT FOR HIV/AIDS
44. HIV/AIDS PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
45. PEDICULOSIS PUBIS U.S. INCIDENCE RATES, 1990-2005
46. MARKET SIZE OF U.S. PEDICULOSIS PUBIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
47. PEDICULOSIS PUBIS PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
48. STAGES OF SYPHILIS
49. SYPHILIS U.S. INCIDENCE RATES BY SEX, 1990-2005
50. SYPHILIS U.S. INCIDENCE RATES BY REGION, 1990-2005
51. MARKET SIZE OF U.S. SYPHILIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
52. SYPHILIS PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
53. TRICHOMONIASIS U.S. INCIDENCE RATES, 1990-2005
54. MARKET SIZE OF U.S. TRICHOMONIASIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
55. TRICHOMONIASIS PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
56. MARKET SIZE OF U.S. STD PRODUCTS BY REVENUES AT U.S. MANUFACTURERS - SALES LEVELS, THROUGH 2005
57. PERCENTAGE OF MANUFACTURERS BY MARKET SEGMENT, 2000
58. SELECTED INDUSTRY PARTICIPANTS BY PRODUCT TYPE

LIST OF FIGURES

• SUMMARY FIGURE:
  MARKET SHARE BY MARKET SEGMENT, 1998-2005

1. BACTERIAL VAGINOSIS U.S. INCIDENCE RATES, 1990-2005
2. MARKET SIZE OF U.S. BACTERIAL VAGINOSIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
3. BACTERIAL VAGINOSIS PRODUCT MANUFACTURER MARKET SHARE, 2000
4. CANDIDIASIS INCIDENCE RATES, 1990-2005
5. MARKET SIZE OF U.S. CANDIDIASIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
6. CANDIDIASIS PRODUCT MANUFACTURER MARKET SHARE, 2000
7. CHANCROID (VENERAL ULCERS) U.S. INCIDENCE RATES, 1990-2005
8. MARKET SIZE OF U.S. CHANCROID (VENERAL ULCERS) PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
9. CHANCROID (VENERAL ULCERS) PRODUCT MANUFACTURER MARKET SHARE, 2000
10. CHLAMYDIA U.S. INCIDENCE RATES BY SEX, 1990-2005
11. CHLAMYDIA U.S. INCIDENCE RATES BY REGION, 1990-2005
12. MARKET SIZE OF U.S. CHLAMYDIA PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
13. CHLAMYDIA PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
14. GENITAL HERPES SIMPLEX VIRUS INFECTIONS U.S. INCIDENCE RATES BY SEX, 1990-2005
15. MARKET SIZE OF U.S. GENITAL HERPES PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
16. GENITAL HERPES PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
17. GENITAL WARTS U.S. INCIDENCE RATES BY SEX, 1990-2005
18. MARKET SIZE OF U.S. GENITAL WART PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
19. GONORRHEA U.S. INCIDENCE RATES BY SEX, 1990-2005
20. GONORRHEA U.S. INCIDENCE RATES BY REGION, 1990-2005
21. MARKET SIZE OF U.S. GONORRHEA PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
22. GONORRHEA PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
23. HEPATITIS B INFECTION (SEXUALLY TRANSMITTED) U.S. INCIDENCE FOR BOTH SEXES, ALL AGES, ALL RACES, 1990-2005
24. MARKET SIZE OF U.S. HEPATITIS B PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
25. HEPATITIS B PRODUCT MANUFACTURER MARKET SHARE BY REVENUES, 2000
26. U.S. AIDS DEATHS BY RACE, 1990-2000
27. MARKET SIZE OF U.S. HIV/AIDS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
28. HIV/AIDS PRODUCT MANUFACTURER MARKET SHARE, 2000
29. PEDICULOSIS PUBIS U.S. INCIDENCE RATES, 1990-2005
30. MARKET SIZE OF U.S. PEDICULOSIS PUBIS PRODUCTSAT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
31. PEDICULOSIS PUBIS PRODUCT MANUFACTURER MARKET SHARE, 2000
32. SYPHILIS U.S. INCIDENCE RATES BY SEX, 1990-2005
33. SYPHILIS U.S. INCIDENCE RATES BY REGION, 1990-2005
34. MARKET SIZE OF U.S. SYPHILIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
35. SYPHILIS PRODUCT MANUFACTURER MARKET SHARE, 2000
36. TRICHOMONIASIS U.S. INCIDENCE RATES, 1990-2005
37. MARKET SIZE OF U.S. TRICHOMONIASIS PRODUCTS AT U.S. MANUFACTURERS - SALES LEVELS, 1998-2005
38. TRICHOMONIASIS PRODUCT MANUFACTURER MARKET SHARE, 2000
39. MARKET SIZE OF U.S. STD PRODUCTS BY REVENUES AT U.S MANUFACTURERS - SALES LEVELS, 1998-2005
40. NUMBER OF SELECTED MANUFACTURERS SUPPLYING MARKET SEGMENTS, 2000
41. MARKET SHARE BY MARKET SEGMENT, 2000